Trademark: 90318022
Word
OEP PHARMA
Status
Dead
Status Code
606
Status Date
Monday, September 12, 2022
Serial Number
90318022
Mark Type
3000
Filing Date
Friday, November 13, 2020
Published for Opposition
Tuesday, June 15, 2021
Abandoned Date
Monday, September 12, 2022

Trademark Owner History
Orient Europharma Co., Ltd. - Owner At Publication

Classifications
5 Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Pharmaceutical products for the prevention and treatment of cancer; Therapeutic pharmaceuticals for the treatment of cancer, cardiovascular diseases, metabolic diseases, musculoskeletal diseases, infectious diseases, and neurodegenerative diseases; Pharmaceutical preparations for the treatment of hyperlipidemia; Local anesthetics; Drug delivery agents in the form of a coating for tablets and capsules that facilitate the delivery of a wide range of pharmaceuticals; Medicinal preparations of the treatment of infectious diseases and for use in oncology; Anesthetics; Anesthetics for surgical purposes; Pharmaceutical preparations for treating diabetes; Anti-diabetic pharmaceuticals; Cardiovascular agents for medical purposes; Drug delivery agents in the form of transdermal patches, coatings for tablets, and synthetic materials that facilitate the delivery of pharmaceutical preparations; Skeletal muscle relaxants; Pharmaceutical preparations for treating hypertension; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations for the treatment of cancer, cardiovascular diseases, metabolic diseases, musculoskeletal diseases, infectious diseases, and neurodegenerative diseases; Anesthetics for surgical and non-surgical use; Pharmaceuticals, namely, lipid lowering agents; Pharmaceutical preparations for use in chemotherapy; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; Transdermal patches for use in the treatment of neurodegenerative disease; Cardiovascular pharmaceuticals; Hypolipidemic agents; Anesthetics for surgical use; Pain relief medication; Pharmaceutical products for the treatment of cancer; Hypolipidemic agents
The mark consists of the stylized words "OEP Pharma" to the right of a miscellaneous design having an overall diamond shape.
"PHARMA"

Trademark Events
Sep 12, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
Sep 12, 2022
Abandonment - No Use Statement Filed
Feb 1, 2022
Notice Of Approval Of Extension Request E-Mailed
Jan 28, 2022
Sou Extension 1 Granted
Jan 28, 2022
Sou Extension 1 Filed
Jan 28, 2022
Teas Extension Received
Aug 10, 2021
Noa E-Mailed - Sou Required From Applicant
Jun 15, 2021
Official Gazette Publication Confirmation E-Mailed
Jun 15, 2021
Published For Opposition
May 26, 2021
Notification Of Notice Of Publication E-Mailed
May 10, 2021
Approved For Pub - Principal Register
May 10, 2021
Examiner's Amendment Entered
May 10, 2021
Notification Of Examiners Amendment E-Mailed
May 10, 2021
Examiners Amendment E-Mailed
May 10, 2021
Examiners Amendment -Written
May 3, 2021
Notification Of Priority Action E-Mailed
May 3, 2021
Priority Action E-Mailed
May 3, 2021
Priority Action Written
Apr 23, 2021
Assigned To Examiner
Jan 14, 2021
Notice Of Design Search Code E-Mailed
Jan 13, 2021
New Application Office Supplied Data Entered In Tram
Nov 17, 2020
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24